These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31429980)

  • 1. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases.
    Murakami T; Yao T; Yatagai N; Yamashiro Y; Saito T; Sakamoto N; Nagahara A
    Histopathology; 2020 Jan; 76(2):325-332. PubMed ID: 31429980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation.
    Yamashiro Y; Saito T; Hayashi T; Murakami T; Yanai Y; Tsuyama S; Suehara Y; Takamochi K; Yao T
    Histopathology; 2020 Sep; 77(3):492-502. PubMed ID: 32438490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
    Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
    Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
    Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
    Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal gut-like differentiation in gallbladder cancer.
    Koyama K; Maeda D; Tamura D; Narita C; Kudo-Asabe Y; Sato T; Yamamoto Y; Sageshima M; Nanjo H; Goto A
    Hum Pathol; 2017 Dec; 70():27-34. PubMed ID: 28970139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNMT3A overexpression is associated with aggressive behavior and enteroblastic differentiation of gastric adenocarcinoma.
    Kataoka I; Funata S; Nagahama K; Isogaya K; Takeuchi H; Abe N; Shibahara J
    Ann Diagn Pathol; 2020 Feb; 44():151456. PubMed ID: 31862523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal adenocarcinoma with enteroblastic differentiation: diagnostic challenges of a rare case encountered in clinical practice.
    Abada E; Anaya IC; Abada O; Lebbos A; Beydoun R
    J Pathol Transl Med; 2022 Mar; 56(2):97-102. PubMed ID: 35051325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
    Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
    BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of alpha-fetoprotein producing early gastric cancer with enteroblastic differentiation.
    Matsumoto K; Ueyama H; Matsumoto K; Akazawa Y; Komori H; Takeda T; Murakami T; Asaoka D; Hojo M; Tomita N; Nagahara A; Kajiyama Y; Yao T; Watanabe S
    World J Gastroenterol; 2016 Sep; 22(36):8203-10. PubMed ID: 27688662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
    Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
    Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
    Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
    Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ureteral Metastasis of Colonic Adenocarcinoma with Enteroblastic Differentiation: A Rare Case to be Distinguished from Clear Cell Adenocarcinoma of the Urinary Tract.
    Minato H; Yoshikawa A; Tsuyama S; Katayanagi K; Hayashi K; Sakimura Y; Bando H; Hori T; Kito Y
    Int J Surg Pathol; 2023 Dec; 31(8):1553-1558. PubMed ID: 36895103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
    Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucin phenotypes and clinicopathological features of colorectal adenocarcinomas: Correlation with colorectal adenocarcinoma with enteroblastic differentiation.
    Kurosawa T; Murakami T; Yamashiro Y; Terukina H; Hayashi T; Saito T; Nojiri S; Sakamoto K; Nagahara A; Yao T
    Pathol Res Pract; 2022 Apr; 232():153840. PubMed ID: 35303523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers.
    He F; Fu Y; Sun Q; Geng P; Zheng Z; Pu X; Shi J; Fan X
    Hum Pathol; 2021 Sep; 115():37-46. PubMed ID: 33636206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological features of rectal adenocarcinoma with enteroblastic differentiation].
    Liu J; Liu XL; Lin DL; Zhao H; Li YJ; Xing XM
    Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):797-801. PubMed ID: 37527983
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
    Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
    Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.